Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
14
Published: June 5, 2023
Ulcerative
colitis
(UC)
is
a
chronic
inflammatory
bowel
disease
involving
mainly
the
colorectal
mucosa
and
submucosa,
incidence
of
which
has
been
on
rise
in
recent
years.
Nuclear
factor
erythroid
2-related
2
(Nrf2),
known
for
its
key
function
as
transcription
factor,
pivotal
inducing
antioxidant
stress
regulating
responses.
Numerous
investigations
have
demonstrated
involvement
Nrf2
pathway
maintaining
development
normal
intestine,
UC,
UC-related
intestinal
fibrosis
carcinogenesis;
meanwhile,
therapeutic
agents
targeting
widely
investigated.
This
paper
reviews
research
progress
signaling
UC.
Gut,
Journal Year:
2024,
Volume and Issue:
73(8), P. 1376 - 1387
Published: May 22, 2024
Background
Metabolic
disorders
and
inflammatory
bowel
diseases
(IBD)
have
captured
the
globe
during
Westernisation
of
lifestyle
related
dietary
habits
over
last
decades.
Both
disease
entities
are
characterised
by
complex
heterogeneous
clinical
spectra
linked
to
distinct
symptoms
organ
systems
which,
on
a
first
glimpse,
do
not
many
commonalities
in
practice.
However,
experimental
studies
indicate
common
backbone
mechanisms
metabolic
gut
inflammation,
emerging
evidence
suggests
an
intricate
interplay
between
IBD.
Objective
We
depict
parallels
IBD
diseases,
easily
overlooked
routine.
Design
provide
overview
recent
literature
discuss
implications
morbidity
patients
with
for
researchers,
clinicians
healthcare
providers.
Conclusion
The
Western
diet
microbial
perturbation
serve
as
fuel
inflammation
beyond
gut.
syndrome
increasingly
affect
IBD,
expected
negative
impact
both
risk
complications.
This
concept
implies
that
tackling
obesity
pandemic
exerts
beneficial
effects
health.
Environment International,
Journal Year:
2025,
Volume and Issue:
195, P. 109258 - 109258
Published: Jan. 1, 2025
Nanoplastics
(NPs)
have
attracted
widespread
attention
owing
to
their
presence
in
the
body.
Recent
studies
highlighted
detrimental
effects
of
NPs
on
digestive
tract.
However,
no
reported
an
association
between
exposure
and
colitis-associated
cancer
(CAC).
An
azoxymethane/dextran
sodium
sulfate-induced
CAC
model
was
used,
polystyrene
nanoparticles
(PS-NPs)
were
selected
for
long-term
exposure.
Non-targeted
metabolomics
16S
rRNA
sequencing
used
detect
changes
colonic
metabolites
gut
microbes
following
PS-NPs
A
lipopolysaccharide
(LPS)-treated
cell
(Caco-2)
exposed
investigate
underlying
molecular
mechanism.
Compared
normal
control
group,
mice
group
exhibited
more
tumor
nodes
reactive
oxygen
species
(ROS),
higher
expression
pan-CK
Ki-67,
severe
DNA
damage.
revealed
that
altered
abundance
Allobaculum
Lactobacillus,
whereas
metabolic
analysis
showed
most
significant
enriched
mostly
fatty
acid
metabolism.
Experiments
LPS
intervened
Caco-2
cells
led
lipid
peroxidation,
oxidative
stress,
damage
Caco-2.
Exposure
activated
phosphatidylinositol
3-kinase
(PI3K)/AKT/mammalian
target
rapamycin
(mTOR)
signaling
pathway
both
AOM/DSS
mouse
cellular
model.
Key
proteins
involved
metabolism
downregulated
PS-NPs.
The
significantly
inhibited
by
activation
fenofibrate.
disturbed
induced
via
PI3K/AKT/mTOR
promote
progression.
Inhibition
is
a
therapeutic
controlling
PS-NP-induced
CAC.
Our
study
provides
important
reference
prevention
treatment
from
perspective
environment
enhances
awareness
necessity
plastic
control.
Molecular Cancer,
Journal Year:
2025,
Volume and Issue:
24(1)
Published: Jan. 24, 2025
Microplastics,
as
an
emerging
environmental
pollutant,
have
received
widespread
attention
for
their
potential
impact
on
ecosystems
and
human
health.
Microplastics
are
defined
plastic
particles
less
than
5
millimeters
in
diameter
can
be
categorized
primary
secondary
microplastics.
Primary
microplastics
usually
originate
directly
from
industrial
production,
while
formed
by
the
degradation
of
larger
items.
capable
triggering
cytotoxicity
chronic
inflammation,
may
promote
cancer
through
mechanisms
such
pro-inflammatory
responses,
oxidative
stress
endocrine
disruption.
In
addition,
improved
bring
new
perspectives
to
therapy,
studies
drug
carriers
underway,
showing
high
targeting
bioavailability.
Although
current
suggest
association
between
certain
cancers
(e.g.,
lung,
liver,
breast
cancers),
long-term
effects
specific
still
need
studied.
This
review
aimed
at
exploring
carcinogenicity
promising
applications
therapy
provides
important
directions
future
research
emphasizes
multidisciplinary
collaboration
address
this
global
health
challenge.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(2), P. 610 - 610
Published: Jan. 13, 2025
The
pentose
phosphate
pathway
(PPP),
traditionally
recognized
for
its
role
in
generating
nicotinamide
adenine
dinucleotide
(NADPH)
and
ribose-5-phosphate
(R5P),
has
emerged
as
a
critical
metabolic
hub
with
involvements
various
gastrointestinal
(GI)
cancers.
PPP
plays
crucial
roles
the
initiation,
development,
tumor
microenvironment
(TME)
of
GI
cancers
by
modulating
redox
homeostasis
providing
precursors
nucleotide
biosynthesis.
Targeting
enzymes
their
regulatory
axis
been
potential
strategy
anti-GI
cancer
therapies.
In
this
review,
we
summarize
mechanisms
enzymes,
elucidate
relationships
between
TME's
elements,
discuss
therapeutic
targeting
Current Opinion in Clinical Nutrition & Metabolic Care,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 14, 2025
Purpose
of
review
This
aims
to
examine
recent
research
on
the
role
specialized
pro-resolving
mediators
(SPMs)
in
regulation
gut
immunophysiology.
Recent
findings
Inflammatory
bowel
disease
(IBD)
is
characterized
by
chronic
inflammation
gastrointestinal
tract,
driven
disruptions
intestinal
barrier
and
an
imbalance
between
host
immune
system
microbiota.
Dietary
polyunsaturated
fatty
acids
(PUFAs),
especially
ω-3
ω-6,
are
key
regulators
responses
help
maintain
integrity
barrier.
These
PUFAs
serve
as
precursors
SPMs,
lipid
that
play
a
critical
resolving
inflammation.
SPMs
actively
reprogram
cells,
promoting
clearance
cellular
debris,
reducing
cytokine
production,
restoring
tissue
homeostasis
without
suppressing
response.
Emerging
evidence
indicates
gut,
strengthen
function,
modulate
colitis
colon
cancer,
influence
microbiota
composition.
Summary
The
strongly
supports
central
maintaining
health
organ
function
following
inflammatory
challenges.
highlights
potential
therapeutic
approaches
target
these
pathways
for
both
prevention
treatment
gut-related
conditions.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(8), P. 4121 - 4121
Published: April 8, 2022
Intestinal
diseases,
such
as
inflammatory
bowel
diseases
(IBDs)
and
colorectal
cancer
(CRC),
are
a
significant
source
of
morbidity
mortality
worldwide.
Epidemiological
data
have
shown
that
IBD
patients
at
an
increased
risk
for
the
development
CRC.
IBD-associated
develops
against
background
chronic
inflammation
oxidative
stress,
their
products
contribute
to
progression.
Therefore,
discovery
novel
drugs
treatment
intestinal
is
urgently
needed.
Licorice
(Glycyrrhiza
glabra)
has
been
largely
used
thousands
years
in
traditional
Chinese
medicine.
its
derived
compounds
possess
antiallergic,
antibacterial,
antiviral,
anti-inflammatory,
antitumor
effects.
These
pharmacological
properties
aid
diseases.
In
this
review,
we
discuss
potential
bioactive
from
addresses
anti-inflammatory
antioxidant
properties.
We
also
how
mechanisms
action
these
can
influence
effectiveness
lead
therapeutic
effects
on
disorders.
Frontiers in Public Health,
Journal Year:
2022,
Volume and Issue:
10
Published: Sept. 7, 2022
Background
To
study
the
corresponding
strategies
to
control
inflammatory
bowel
disease
(IBD),
a
comprehensive
assessment
of
burden
is
required.
Herein,
we
present
long-term
trends
in
IBD
China
over
last
three
decades,
as
well
its
epidemiological
features.
Methods
We
characterized
using
GBD
2019
methods
and
results,
based
on
prevalence,
incidence,
mortality,
years
lost
(YLLs),
lived
with
disability
(YLDs),
disability-adjusted
life
(DALYs)
estimated
DisMod-MR
2-1.
also
used
joinpoint
age-period-cohort
(apc)
analysis
interpret
characteristics
compare
them
global
prevalence
trends.
Results
The
age-standardized
incidence
mortality
rates
both
sexes
changed
from
1.47
(95%
CI:
1.24,
1.74)
3.01
2.59,
3.50)
0.86
0.59,
1.16)
0.30
0.24,
0.35)
per
100,000
people
1990
2019.
DALY
rate
decreased
24.47
17.88,
30.19)
13.10
10.29,
16.31)
average
annual
percentage
change
(AAPC)
for
were
2.51
2.44,
2.57),
2.53
2.41,
2.66),
−3.62
−3.85,
−3.39).
effects
age,
period,
cohort
differed.
Conclusions
increasing
are
contributed
by
reduction
DALYs,
compounded
rise
between
China.
will
be
major
public
health
challenge,
given
country's
large
population
base
aging
population.